Next Article in Journal
Cryptococcal Lymphadenitis in an HIV-Infected Patient: A Rare Manifestation of Immune Reconstitution Inflammatory Syndrome
Previous Article in Journal
Sporotrichoid Skin Infection Caused by Nocardia brasiliensis in a Kidney Transplant Patient
Previous Article in Special Issue
Role of Handheld In Vivo Reflectance Confocal Microscopy for the Diagnosis of Fabry Disease: A Case Report
Article Menu
Issue 3 (September) cover image

Export Article

Open AccessFeature PaperReview
Diseases 2018, 6(3), 69; https://doi.org/10.3390/diseases6030069

The Importance of a Multidisciplinary Approach in the Management of a Patient with Type I Gaucher Disease

Aragon Health Research Institute (ISS Aragón), Department of Internal Medicine, Unit of Rare Disorders, “Lozano Blesa” University Hospital, 15th San Juan Bosco Avenue, 50009 Zaragoza, Spain
*
Author to whom correspondence should be addressed.
Received: 3 July 2018 / Revised: 20 July 2018 / Accepted: 23 July 2018 / Published: 26 July 2018
(This article belongs to the Collection Lysosomal Storage Diseases)
Full-Text   |   PDF [2908 KB, uploaded 26 July 2018]   |  

Abstract

Managing the multisystemic symptoms of type I Gaucher Disease (GD) requires a multidisciplinary team approach that includes disease-specific treatments, as well as supportive care. This involves a range of medical specialists, general practitioners, supportive care providers, and patients. Phenotype classification and the setting of treatment goals are important for optimizing the management of type I GD, and for providing personalized care. The ability to classify disease severity using validated measurement tools allows the standardization of patient monitoring, and the measurement of disease progression and treatment response. Defining treatment goals is useful to provide a benchmark for assessing treatment response and managing the expectations of patients and their families. Although treatment goals will vary depending on disease severity, they include the stabilization, improvement or reversal (if possible) of clinical manifestations. Enzyme replacement therapy (ERT) is the standard care for patients with type I GD, but a novel substrate reduction therapy (SRT), Eliglustat, has demonstrated safety and efficacy in selected patients. To ensure that treatment goals are being achieved, regular and comprehensive follow up are necessary. View Full-Text
Keywords: multidisciplinary; Gaucher; genotype/phenotype correlation; genetic counselling multidisciplinary; Gaucher; genotype/phenotype correlation; genetic counselling
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Torralba-Cabeza, M.-Á.; Olivera-González, S.; Sierra-Monzón, J.-L. The Importance of a Multidisciplinary Approach in the Management of a Patient with Type I Gaucher Disease. Diseases 2018, 6, 69.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Diseases EISSN 2079-9721 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top